Health & bio

Retatrutide -28.7% Weight Loss, -75.8% Pain

In obese adults with knee osteoarthritis, Retatrutide delivered mean -28.7% weight loss and WOMAC pain reduction of -75.8%. Regulatory submission expected in 2026.

Primary sources · 1
← View the full 2026-04-12 (Sun) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →